Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

1 Cannabis Stock to Avoid At All Costs


Cannabis company HEXO (NYSE: HEXO) has several things going its way. For instance, the pot grower teamed up with alcoholic beverage maker Molson Coors (NYSE: TAP) in 2018, and out of this partnership was born a joint venture, dubbed Truss Beverages. HEXO is looking to make a dent in the potentially lucrative cannabis derivative market in Canada via this joint venture.

Through its acquisition of Newstrike Brands for 263 million Canadian dollars (about $201 million) in March 2019, HEXO was able to increase its production capacity. With a projected peak output of about 150,000 kilograms per year, HEXO now ranks in the top 10 pot growers in Canada by production capacity.

Furthermore, HEXO holds the leading market share in the adult-use cannabis market in Quebec, which is the second-largest Canadian province by population. Despite these advantages, HEXO -- which saw its shares plunge by 53.6% last year -- shouldn't be on the list of cannabis stocks you want to buy. Here's why. 

Continue reading


Source Fool.com

Like: 0
TAP
Share

Comments